A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Clinical trial NCT03592472 · RECRUITING
Trial details
- NCT number
- NCT03592472
- Sponsor
- Xynomic Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-17
- Primary completion
- 2026-12-30
- Enrollment
- 413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.